Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ATXI Avenue Therapeutics > Detailed Quotes

ATXI Avenue Therapeutics

6.290
-2.180-25.74%
Close 10/06 16:00 ET
5.610
-0.680-10.81%
Post Mkt Price 10/06 19:59 ET
High
8.420
Open
7.600
Turnover
20.05M
Low
6.140
Pre Close
8.470
Volume
2.71M
Market Cap
9.52M
P/E(TTM)
Loss
52wk High
27.750
Shares
1.51M
P/E(Static)
Loss
52wk Low
3.000
Float Cap
5.01M
Bid/Ask %
92.00%
Historical High
185.097
Shs Float
797.06K
Volume Ratio
0.20
Historical Low
3.000
Dividend TTM
--
Div Yield TTM
--
P/B
16.13
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
339.80%
Amplitude
26.92%
Avg Price
7.401
Lot Size
1
Float Cap
5.01M
Bid/Ask %
92.00%
Historical High
185.097
Shs Float
797.06K
Volume Ratio
0.20
Historical Low
3.000
Dividend TTM
--
P/B
16.13
Dividend LFY
--
Turnover Ratio
339.80%
Amplitude
26.92%
Avg Price
7.401
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in New York, NY.
CEO: Dr. Alexandra MacLean, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...